The role of serum response factor in hepatocellular carcinoma: An association with matrix metalloproteinase

Oncology Reports

Volumn 26, Issue 6, 2011, Pages 1567-1572

  Kim, Kyung Ryoul ^a   Bae, Jun Sang ^a   Choi, Ha Na ^a   Park, Ho Sung ^a   Jang, Kyu Yun ^a   Chung, Myoung Ja ^a   Moon, Woo Sung ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Carcinoma; Hepatocellular; Matrix metalloproteinases; Serum response factor

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; SERUM RESPONSE FACTOR;

ARTICLE; CANCER CELL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SRF GENE; UPREGULATION; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ASSAYS; GENE EXPRESSION; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RECOMBINANT PROTEINS; SERUM RESPONSE FACTOR;

EID: 80053494147     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1421     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
3. Befeler AS and Di Bisceglie AM: Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122: 1609-1619, 2002. (Pubitemid 34533556)
4. Treisman R: Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46: 567-574, 1986.
5. Treisman R: Identification and purification of a polypeptide that binds to the c-fos serum response element. EMBO J 6: 2711-2717, 1987.
6. Shore P and Sharrocks AD: The MADS-box family of transcription factors. Eur J Biochem 229: 1-3, 1995.
7. Norman C, Runswick M, Pollock R and Treisman R: Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 55: 989-1003, 1988. (Pubitemid 19020052)
8. Modak C and Chai J: Serum response factor: look into the gut. World J Gastroenterol 16: 2195-2201, 2010.
9. Chai J and Tarnawski AS: Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing. J Physiol Pharmacol 53: 147-157, 2002. (Pubitemid 34717237)
10. Schratt G, Weinhold B, Lundberg AS, Schuck S, Berger J, Schwarz H, Weinberg RA, Ruther U and Nordheim A: Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells. Mol Cell Biol 21: 2933-2943, 2001. (Pubitemid 32244935)
11. Chai J, Baatar D and Tarnawski A: Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing. Gastroenterology 126: 1809-1818, 2004. (Pubitemid 38736346)
12. Psichari E, Balmain A, Plows D, Zoumpourlis V and Pintzas A: High activity of serum response factor in the mesenchymal transition of epithelial tumor cells is regulated by RhoA signaling. J Biol Chem 277: 29490-29495, 2002. (Pubitemid 41079235)
13. Kwon CY, Kim KR, Choi HN, Chung MJ, Noh SJ, Kim DG, Kang MJ, Lee DG and Moon WS: The role of serum response factor in hepatocellular carcinoma: Implications for disease progression. Int J Oncol 37: 837-844, 2010.
14. Page-McCaw A, Ewald AJ and Werb Z: Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221-233, 2007.
15. Parks WC, Wilson CL and Lopez-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4: 617-629, 2004. (Pubitemid 39025047)
16. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002. (Pubitemid 37328786)
17. Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
18. Giannelli G, Bergamini C, Marinosci F, Fransvea E, Quaranta M, Lupo L, Schiraldi O and Antonaci S: Clinical role of MMP-2/ TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer 97: 425-431, 2002. (Pubitemid 34027799)
19. Sakamoto Y, Mafune K, Mori M, Shiraishi T, Imamura H, Mori M, Takayama T and Makuuchi M: Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma. Int J Oncol 17: 237-243, 2000.
20. Choi HN, Kim KR, Lee JH, Park HS, Jang KY, Chung MJ, Hwang SE, Yu HC and Moon WS: Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/β-catenin complex. Oncol Rep 21: 57-63, 2009.
21. Kim HJ, Kim KR, Park HS, Jang KY, Chung MJ, Shong M and Moon WS: The expression and role of serum response factor in papillary carcinoma of the thyroid. Int J Oncol 35: 49-55, 2009.
22. Farra R, Dapas B, Pozzato G, Giansante C, Heidenreich O, Uxa L, Zennaro C, Guarnieri G and Grassi G: Serum response factor depletion affects the proliferation of the hepatocellular carcinoma cells. HepG2 and JHH6. Biochimie 92: 455-463, 2010.
23. Park MY, Kim KR, Park HS, Park BH, Choi HN, Jang KY, Chung MJ, Kang MJ, Lee DG and Moon WS: Expression of the serum response factor in hepatocellular carcinoma: Implications for epithelial-mesenchymal transition. Int J Oncol 31: 1309-1315, 2007.
24. Park SY, Jang KY, Kim YN, Kim HJ, Park HS, Chung MJ, Yu HC, Cho BH, Kim KR and Moon WS: Expression and prognostic significance of serum response factor in cholangiocarcinoma. Korean J Pathol 43: 517-522, 2009.
25. Zhe X, Yang Y, Jakkaraju S and Schuger L: Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis: potential consequence of abnormal serum response factor expression. Am J Respir Cell Mol Biol 28: 504-511, 2003. (Pubitemid 36399373)
26. Zhe X, Yang Y and Schuger L: Imbalanced plasminogen system in lymphangioleiomyomatosis: potential role of serum response factor. Am J Respir Cell Mol Biol 32: 28-34, 2005. (Pubitemid 40053301)
27. Sampieri CL, Nuttall RK, Young DA, Goldspink D, Clark IM and Edward DR: Activatin of p38 and JNK MAP kinase pathways abrogates requirement for new protein synthesis for phorbol ester mediated induction of select MMP and TIMP genes. Matrix Biol 27: 128-138, 2008. (Pubitemid 351221010)
28. Yan C and Boyd DD: Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211: 19-26, 2007. (Pubitemid 46363892)